Skip to content

Vibration Exercise in the treatemnt of Shoulder Adhesive Capsulits - an Integrated Therapeutic concept

Vibration Exercise in the treatemnt of Shoulder Adhesive Capsulits - an Integrated Therapeutic concept

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
DRKS
Registry ID
DRKS00012742
Enrollment
25
Registered
2017-07-13
Start date
2017-07-17
Completion date
Unknown
Last updated
2025-04-07

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Adhesive capsulitis, shoulder M25.6

Interventions

Group 1: 3x per week physical therapy + vibration exercise using Galileo Mano, alltogether for 18 weeks Group 2: 3x per week physical therapy for 18 weeks

Sponsors

Klinische Studieneinheit, Orthopädische Klinik, Universität Würzburg
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to No maximum

Inclusion criteria

Inclusion criteria: • Diagnosis of adhesive Capsulitis • Age = 18 years • Functional limitation (Constant-Score, Range of Motion) • Limited range of motion in glenohumeral joint: external rotation =30°, abduction =90°

Exclusion criteria

Exclusion criteria: • Surgery at index shoulder within = 56 Tage before enrollement • Neurologically ascertained plexus lesion • Endoprostetic joint replacment at the index shoulder • Non-healed fracture of humerus or scapula at the affected shoulder • Other medical reasons that according to the investigators assessment might impose an increased risk for the patient

Design outcomes

Primary

MeasureTime frame
Functional improvement of affected shoulder comparing both interventions at 18 weeks. Quantitative assessment is performed by means of the Constant-ScoreV at 9 weeks (interim analysis) and 18 weeks (final assessment).

Secondary

MeasureTime frame
I) Range of motion for abduction, adduction, internal-/external rotation, anteversion and retroversion II) Subjective perception of symptoms using ADL- and DASH-Score III) Pain, assessed via VAS-Score IV) Correlation of outcome measures with data obtained in clinical routine settings V) Consumption of analgesics Assessments will be performed at 9 weeks (Interim analysis) und 18 weeks (final assessmet)

Countries

Germany

Contacts

Public ContactLothar Seefried

Klinische Studieneinheit, Orthopädische Klinik, Universität Würzburg

l-seefried.klh@uni-wuerzburg.de+49 931 803 3575

Outcome results

None listed

Source: DRKS (via WHO ICTRP) · Data processed: Feb 4, 2026